Paid Clinical Trials Jackson
Discover 103 paid clinical trials in Jackson, Mississippi. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
AcyclovirPhase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System
Sponsor:
National Center for Research Resources (NCRR)
Location:
Code:
NCT00006132
Conditions
Herpes Simplex
Eligibility Criteria
Sex: All
Age: 0 - 28
Healthy Volunteers: Not accepted
Interventions
acyclovir
Observational StudyADVENT Post Approval Study
Sponsor:
Boston Scientific Corporation
Location:
Code:
NCT06431815
Conditions
Paroxysmal Atrial Fibrillation
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
FARAPULSE™ Pulsed Field Ablation System
OBT076Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors
Sponsor:
Oxford BioTherapeutics Ltd
Location:
Code:
NCT04064359
Conditions
Solid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
OBT076, a CD205-directed antibody-drug conjugate
OCTAPLEXStudy of OCTAPLEX in Patients With Acute Major Bleeding on DOAC Therapy With Factor Xa Inhibitor
Sponsor:
Octapharma
Location:
Code:
NCT04867837
Conditions
Acute Major Bleeding
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Octaplex
Diuretics vs. AortixDiuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Sponsor:
Procyrion
Location:
Code:
NCT05677100
Conditions
Heart Failure
Cardiorenal Syndrome
Cardio-Renal Syndrome
ADHF
Heart Failure, Systolic
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Not accepted
Interventions
Aortix System
Immulina TMEffects of Immulina TM Supplements with PASC Patients
Sponsor:
University of Mississippi Medical Center
Location:
Code:
NCT05524532
Conditions
Post Acute COVID-19 Syndrome
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Interventions
Immulina TM
Placebo
Observational StudyCord Clamping Among Neonates with Congenital Heart Disease
Sponsor:
Carl Backes, MD
Location:
Code:
NCT06153459
Conditions
Congenital Heart Disease (CHD)
Eligibility Criteria
Sex: All
Age: 37 - 42
Healthy Volunteers: Not accepted
Interventions
Umbilical Cord Clamping at ~30 seconds
Umbilical Cord Clamping at ~120 seconds
Umbilical Cord Milking
CoLink® PCR MTP PlateA Post-market Clinical Study to Evaluate the Safety and Performance of the Carbon Fibre Reinforced Polyetheretherketone Metatarso-Phalangeal (MTP) Plate (CoLink® PCR MTP Plate) for the Treatment of Hallux Rigidus
Sponsor:
Invibio Ltd
Location:
Code:
NCT05692687
Conditions
Hallux Rigidus
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
ONC-392 & Lutetium Lu 177ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC
Sponsor:
OncoC4, Inc.
Location:
Code:
NCT05682443
Conditions
Metastatic Castration-resistant Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ONC-392 low
ONC-392 high
lutetium Lu 177 vipivotide tetraxetan
BAY2862789A First-in-human Study to Learn How Safe the Study Treatment BAY2862789 is, to Find the Best Dose, How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, and How it Acts on Different Tumors in Participants With Advanced Solid Tumors
Sponsor:
Bayer
Location:
Code:
NCT05858164
Conditions
Advanced Solid Tumors
Non-small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BAY2862789